Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

The decision will impact 22 projects speerheaded by major pharmaceutical companies for vaccines against bird flu and other ...

BioNTech stock was rising after the drugmaker reported better-than-expected results on Monday. In early trading, the ...

CureVac (CVAC) and GSK (GSK) to receive $740M and other payments in a settlement with Pfizer (PFE) and BioNTech (BNTX) over ...

Shares of the biotech were up 4.3% in premarket trading, after it also beat Wall Street expectations for second-quarter ...

The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to create new mRNA vaccines. Experts say this could potentially impact mRNA ...

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA vaccine research.

President Donald Trump’s vaccine-bashing secretary of health and human services is canceling $500 million worth of vaccine ...

WASHINGTON -- So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...

The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA ...

The US vaccines market, valued at $29.5B in 2024, is projected to reach $60B by 2033, at a CAGR of 8.2%. Key growth drivers include rising infectious diseases and biotech advancements. Comprehensive ...